Migraine drug fremanezumab tested for sleep benefits
Symptom relief
Terminated
This study looked at whether fremanezumab, an FDA-approved migraine prevention drug, could also improve sleep quality in people with migraines. Researchers planned to track 22 adults aged 18-65 who have frequent migraines, measuring their sleep and migraine days before and during…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Apr 26, 2026 20:02 UTC